- Overview
- Sessions
- Speakers
- Thought Leadership
Overview
KPMG in Boston hosts the annual Life Sciences Future Pathways Forum
Welcome to the Future of Health Care, where the technology-enabled patient-centric journey of the future will occur. As we speak, groundbreaking advancements are being developed, deployed, and administered through advancements in precision medicine – impacting approaches in screening, diagnosis and therapy selection – all supported by developments in AI and advancements in 5G technology.
In recent years, we've seen precision medicine radically alter the opportunities for diagnosis and therapy development. Now, fast-moving advances in 5G technology in laboratories and hospitals introduce the collaborative power of artificial intelligence to further enhance patient outcomes.
KPMG's Life Sciences Future Pathways forum is an opportunity to connect and explore how bridges are being built and to visualize the potential extraordinary outcomes enabled by the Patient-Centric Journey of the Future.
Special guest contributors are a hallmark of the Life Sciences Future Pathways Forum
To produce the forum in a way that reflects an unvarnished look at the current state of the industry, KPMG brings together our most senior thought leaders with senior industry executives to bring you well-rounded, sometimes provocative, and always hyper-relevant perspectives on trending topics that the life sciences sector is facing.
You're in good company at the Life Sciences Future Pathways Forum
Building lasting connections with industry peers is critical no matter your professional level or industry segment. Because our Life Sciences Future Pathways Forum attracts hundreds of professionals from all levels of the organizational hierarchy, you'll have an opportunity to meet new contacts and peers, strengthen existing relationships, and build connections that will pay dividends for years.
Audience breakdown shown has been derived from the most recent forum registration data
Sessions
2:00pm - 3:00pm: Transforming patient treatment through innovative therapies
During this session, you will hear from subject matter professionals in the field who are developing new therapies, treatments, and vaccines. From precision medicine to gene therapies, learn about treatment innovations that are unlocking the next evolution in patient care.
During this session, you will hear from subject matter professionals in the field who are developing new therapies, treatments, and vaccines. From precision medicine to gene therapies, learn about treatment innovations that are unlocking the next evolution in patient care.
9:30am - 10:30am: Tech Risk Trends in Financial Services ft. ServiceNow
Over a short span of just a few months, financial services firms have witnessed a veritable revolution in technological change; transition to hybrid cloud environments, the rollout of rapid application development using DevOps methods, and the urgent adoption of work from home applications. KPMG’s Technology Risk leaders Tina Thukalil and Matthew Miller along with financial industry leaders Gregory Kanevski, Kristin Streett, and Alison Musci from ServiceNow will break down what’s going on in the areas of cyber, data governance, regulatory compliance, third party risk, and legacy risk which can all have devastating effects on a firms ability to transact business if not managed properly.
10:30am - 11:00am: Increasing Operational Efficiency and Profitability through Advanced Analytics
In this session, we will discuss how leading companies are using advanced analytics and supply chain modeling to find new ways to increase profits (and lower risk) through complexity reduction. We will share practical examples of how Big Data platforms can reveal hidden opportunities (beyond the reach of traditional approaches) – and share innovations from other sectors that can be adopted by life sciences companies today. We will also show live demonstrations of actual decision-making models that can be used on a wide range of use cases to unlock value within the first 6-9 months.
In this session, we will discuss how leading companies are using advanced analytics and supply chain modeling to find new ways to increase profits (and lower risk) through complexity reduction. We will share practical examples of how Big Data platforms can reveal hidden opportunities (beyond the reach of traditional approaches) – and share innovations from other sectors that can be adopted by life sciences companies today. We will also show live demonstrations of actual decision-making models that can be used on a wide range of use cases to unlock value within the first 6-9 months.
10:30am - 11:30am: The New Role of ESG in Banking, Asset Management & Enterprise ft. PIMCO
KPMG’s Liz Ming will give an overview of new expectations and requirements around ESG for enterprise companies the firm is working with as well as some of the solutions for managing them. Afterward, we’re pulling together practitioners who are overseeing and making positive changes including Katherine Blue, KPMG’s Sustainability Service Leader for the Americas, Olivia Albrecht, Head of ESG Strategy for PIMCO, and some of the tech that’s aiding in these efforts for a discussion of where we were, where we are, and where we’re going.
3:00pm- 4:00pm: The implications of new technologies on patient care
The future of the healthcare experience will involve further digitizing the healthcare system to improve the user experience and outcomes for the patient and provider while driving operational efficiencies on the backend. And, 5G is the enabling technology to bring together a variety of use cases into one seamless, interoperable environment. This session will bring together industry professionals to discuss new technology and its implications on patient care.
The future of the healthcare experience will involve further digitizing the healthcare system to improve the user experience and outcomes for the patient and provider while driving operational efficiencies on the backend. And, 5G is the enabling technology to bring together a variety of use cases into one seamless, interoperable environment. This session will bring together industry professionals to discuss new technology and its implications on patient care.
4:00pm- 5:00pm: Reimagining the hospital of the future
This session will bring everything together to discuss what the future of healthcare truly looks like and where industry experts think major changes are coming first, second, and third. We will share how relationships between hospitals and life science companies are bringing biotech, biopharma, and medtech companies ever-closer to the patients that benefit from their treatments.
This session will bring everything together to discuss what the future of healthcare truly looks like and where industry experts think major changes are coming first, second, and third. We will share how relationships between hospitals and life science companies are bringing biotech, biopharma, and medtech companies ever-closer to the patients that benefit from their treatments.
5:00pm- 6:00pm: Cocktail Reception
12:00pm - 1:00pm: Client-Centric Relationships in the New Reality ft. Humana, USAA, Edward Jones, PayPal, Salesforce
How has the new reality changed the way financial services firms build relationships with their clients? Shifts in consumer behavior, accelerated by COVID-19, require firms to improve the client experience through a new rhythm of positive interactions—delivered in the digital world.
Join Michael Herman from KPMG and Rohit Mahna from Salesforce for a discussion on the ways that transformation within the financial services industry is helping firms improve both the customer experience and their own performance. A panel of customer experience executives from USAA, Edward Jones, PayPal and Humana will share how digital transformation enabled them to implement a client-centric culture to build strong and enduring relationships.
.
1:30pm - 2:30pm: The Future of FinTech ft. Silicon Valley Bank, MassChallenge, InterGen Data, FiVerity
The Future of Fintech is already here, sometimes it just needs a little help along the way. Massachusetts has a vast array of resources for innovators in the space with MassChallenge, the Mass Tech Collaborative, public sector innovation leaders, and anchor financial institutions across the state with labs to help develop ideas, technology, and leaders.
This panel discussion will bring together mentors from these programs including Rob Baldassare, Principal at KPMG, Devon Sherman, MassChallenge’s Fintech Managing Director, Dan Allred, Senior Market Manager for Silicon Valley Bank’s National Fintech & Payments Strategy Team, Robert Kirk, CEO of InterGen Data, and Greg Woolf, CEO of FiVerity, who will all give insight into where the next hot areas of the space are, where the saturation points might be, and how we keep Massachusetts on the forefront of fintech innovation.
All sessions shown are eligible for Continuing Professional Education (CPE) credits
Sessions for the Techonomy CDX Health & Wellness event can be found here
Speakers
Michael Buchanio
Managing Director, Deal Advisory & Strategy
KPMG LLP
Ryan Clements
Managing Director
KPMG LLP
Greg Corlis
Principal, National IoT and Private Networks Leader
KPMG LLP
David Frey
Principal, NEUNY Life Sciences Lead
KPMG LLP
Robin Goldsmith
Health Innovation Principal
Verizon
Kristin Pothier
Principal, Global Strategy Leader, Healthcare & Life Sciences
KPMG LLP
Jeff Stoll
Principal, National Strategy Leader
KPMG LLP
Thought Leadership
Previous forums
- Prior forum speakers
- Faces of the forum